Types of Ethics Committees in Research
Classification and Structure of Research Ethics Review Bodies · Also known as: IRB, REC, Ethics Committee, Institutional Review Board, Research Ethics Committee
Research ethics committees are independent governance bodies established to review and oversee human subjects research. In the United States, these are called Institutional Review Boards (IRBs); in the United Kingdom and Commonwealth nations, Research Ethics Committees (RECs); and in European Union and other jurisdictions, they are termed Ethics Committees. These bodies operate under national regulations—45 CFR 46 in the U.S., the Medicines for Human Use (Clinical Trials) Regulations in the UK, and the EU Clinical Trials Regulation in Europe—to ensure research protects participant rights, safety, and welfare.
Read the full method
Sign in with a free account to read this section.
Method map
The neighbourhood of related methods — select a node to explore.
When to use it
Identify the relevant ethics committee before beginning any study involving human subjects, including research with human tissue or data. Determine committee type based on: institutional setting (university, hospital, private company), research risk level (minimal to high), participant population (vulnerable or general), and geographic scope (single-site, multi-site, international). If your study involves clinical research, drug/device testing, or vulnerable populations, full board review is mandatory. If observational or survey-based with low risk to healthy adults, expedited or exempt review may apply (if regulations permit). International research requires approval from ethics committees in each participating country.
Strengths & limitations
- Independent ethical oversight prevents exploitation and harm; committees include community representatives and non-scientists to ensure non-expert perspective.
- Standardized review processes (application, documentation, decision categories) provide consistency and transparency across institutions.
- Regulatory authority: ethics committees can halt unethical research mid-study; compliance is legally binding.
- Diverse committee membership (scientist, non-scientist, community, unaffiliated member) incorporates multiple viewpoints on study acceptability.
- Variable committee expertise: a social science IRB may not fully evaluate biomedical risk; a hospital ethics committee may lack social science methodology knowledge.
- Delay to research start: full board reviews can extend timelines by 4-6 weeks or longer, particularly for complex protocols.
- Geographic variation: standards and rigor differ markedly across countries and even between institutions in the same country, creating inconsistency in multi-site trials.
- Limited resources: committees with high workload may allocate limited time to each protocol review, potentially missing important ethical concerns.
Frequently asked
What is the difference between an IRB and an REC?
An Institutional Review Board (IRB) is the U.S. term for the research ethics committee as defined in 45 CFR 46. A Research Ethics Committee (REC) is the equivalent in the UK, European Union, Australia, and other Commonwealth nations. The fundamental function is identical—independent ethical review of human subjects research—but regulatory frameworks, membership requirements, and operational procedures differ by country. An IRB operates under U.S. federal law; an REC operates under UK legislation (Health Research Authority) or EU Clinical Trials Regulation. When conducting research in a given country, researchers must obtain approval from that country's ethics body (IRB if U.S., REC if UK, etc.).
Can a single ethics committee approve a multi-site trial?
Not entirely. In multi-site trials, the coordinating site's IRB/REC may review the protocol centrally to ensure consistency, but each participating site must have ethics approval from its own institutional IRB/REC. In the UK, a single Research Ethics Committee may conduct centralized review for NHS-related research across multiple NHS trusts; a single decision applies to all sites. In the U.S., the FDA allows cooperative agreements where one IRB serves as the reviewing board for all sites (central IRB review), but this requires written agreements between all participating institutions and is increasingly common in large trials. International trials require separate approvals in each country.
When is ethics approval not required?
Some low-risk research may be exempt from full ethics review under regulatory definitions. In the U.S., 45 CFR 46.104 lists six categories of exempt research: (1) research in an educational setting involving educational practices/curricula, (2) research involving collection of educational tests/survey data, (3) research on existing de-identified data or specimens, (4) research on publicly available data, (5) taste/quality evaluations of food/beverages, and (6) certain types of public benefit and service programs research. In the UK, some health services research may not require REC review if it qualifies as audit or evaluation of established practice, but this distinction is increasingly narrow. Many institutions require expedited review even for exempt studies to document the exemption. Researchers must check their institution's policy—the existence of an exemption category does not automatically exempt a study; the IRB/REC must make the determination.
What happens if I conduct research without ethics approval?
Conducting human subjects research without ethics approval is a serious breach with legal and professional consequences. The research cannot be published in ICMJE-member journals (98% of major medical journals), which require ethics approval as a publication condition. Institutions can impose sanctions on investigators: suspension of research privileges, loss of institutional affiliation, or termination of employment. Funding agencies (NIH, NSF, Wellcome Trust, EU) require ethics approval as a grant condition and may impose funding restrictions if violations are discovered. Professional bodies (medical boards, psychological associations) may discipline members who conduct unapproved research. In some cases, particularly if research causes harm, civil liability or criminal charges may result. Additionally, any data collected is typically unusable and cannot be ethically analyzed or published.
Sources
- U.S. Department of Health and Human Services. (2018). Protection of Human Subjects. Code of Federal Regulations Title 45, Part 46. link ↗
- U.S. Food and Drug Administration. (2013). Institutional Review Boards: Frequently Asked Questions. Center for Drug Evaluation and Research. link ↗
- International Council for Harmonisation. (2016). ICH Harmonised Guideline: Integrated Addendum to ICH E6(R1). Good Clinical Practice E6(R2). link ↗
How to cite this page
ScholarGate. (2026, June 4). Classification and Structure of Research Ethics Review Bodies. ScholarGate. https://scholargate.app/en/research-ethics/ethics-committee-types
Which method?
Set this method beside its closest kin and read them side by side — the library lays the books on the table; the choice is yours.
- Clinical Trial RegistrationResearch Ethics↔ compare
- Ethics Committee Application ProcessResearch Ethics↔ compare
- Research with Vulnerable PopulationsResearch Ethics↔ compare
- Risk-Benefit Assessment in Research ProtocolsResearch Ethics↔ compare
- Waiver of Informed Consent in ResearchResearch Ethics↔ compare